Barclays’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$700K Buy
321,231
+206,459
+180% +$450K ﹤0.01% 2863
2025
Q1
$314K Sell
114,772
-49,260
-30% -$135K ﹤0.01% 3106
2024
Q4
$683K Sell
164,032
-1,733
-1% -$7.22K ﹤0.01% 2872
2024
Q3
$645K Buy
165,765
+127,156
+329% +$495K ﹤0.01% 2850
2024
Q2
$151K Sell
38,609
-40,623
-51% -$159K ﹤0.01% 3189
2024
Q1
$332K Sell
79,232
-58,599
-43% -$246K ﹤0.01% 3066
2023
Q4
$648K Buy
137,831
+106,266
+337% +$500K ﹤0.01% 2858
2023
Q3
$98K Sell
31,565
-3,359
-10% -$10.4K ﹤0.01% 3337
2023
Q2
$159K Sell
34,924
-42,954
-55% -$196K ﹤0.01% 3197
2023
Q1
$386K Buy
77,878
+47,281
+155% +$234K ﹤0.01% 2809
2022
Q4
$166K Buy
30,597
+19,377
+173% +$105K ﹤0.01% 3201
2022
Q3
$72K Sell
11,220
-1,572
-12% -$10.1K ﹤0.01% 3536
2022
Q2
$61K Sell
12,792
-20,437
-62% -$97.5K ﹤0.01% 3656
2022
Q1
$233K Buy
33,229
+32,039
+2,692% +$225K ﹤0.01% 3221
2021
Q4
$12K Sell
1,190
-29
-2% -$292 ﹤0.01% 3136
2021
Q3
$15K Buy
+1,219
New +$15K ﹤0.01% 3687